North Star Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
6,852
-30
| -0.4% | -$2.35K | 0.04% | 304 |
|
|
2025
Q1 | $499K | Hold |
6,882
| – | – | 0.04% | 316 |
|
|
2024
Q4 | $509K | Hold |
6,882
| – | – | 0.04% | 322 |
|
|
2024
Q3 | $454K | Hold |
6,882
| – | – | 0.03% | 330 |
|
|
2024
Q2 | $636K | Hold |
6,882
| – | – | 0.05% | 292 |
|
|
2024
Q1 | $658K | Hold |
6,882
| – | – | 0.05% | 293 |
|
|
2023
Q4 | $525K | Hold |
6,882
| – | – | 0.04% | 318 |
|
|
2023
Q3 | $477K | Hold |
6,882
| – | – | 0.04% | 331 |
|
|
2023
Q2 | $649K | Hold |
6,882
| – | – | 0.05% | 304 |
|
|
2023
Q1 | $569K | Buy |
6,882
+6,000
| +680% | +$496K | 0.05% | 328 |
|
|
2022
Q4 | $65.8K | Buy |
882
+30
| +4% | +$2.24K | 0.01% | 557 |
|
|
2022
Q3 | $70K | Hold |
852
| – | – | 0.01% | 486 |
|
|
2022
Q2 | $81K | Hold |
852
| – | – | 0.01% | 477 |
|
|
2022
Q1 | $100K | Hold |
852
| – | – | 0.01% | 467 |
|
|
2021
Q4 | $110K | Hold |
852
| – | – | 0.01% | 469 |
|
|
2021
Q3 | $96K | Hold |
852
| – | – | 0.01% | 479 |
|
|
2021
Q2 | $88K | Hold |
852
| – | – | 0.01% | 497 |
|
|
2021
Q1 | $71K | Buy |
852
+612
| +255% | +$51K | 0.01% | 495 |
|
|
2020
Q4 | $22K | Hold |
240
| – | – | ﹤0.01% | 666 |
|
|
2020
Q3 | $19K | Hold |
240
| – | – | ﹤0.01% | 665 |
|
|
2020
Q2 | $17K | Hold |
240
| – | – | ﹤0.01% | 654 |
|
|
2020
Q1 | $15K | Hold |
240
| – | – | ﹤0.01% | 670 |
|
|
2019
Q4 | $19K | Hold |
240
| – | – | ﹤0.01% | 715 |
|
|
2019
Q3 | $18K | Buy |
+240
| New | +$18K | ﹤0.01% | 722 |
|
|
2019
Q2 | – | Sell |
-240
| Closed | -$15K | – | 563 |
|
|
2019
Q1 | $15K | Hold |
240
| – | – | ﹤0.01% | 760 |
|
|
2018
Q4 | $12K | Hold |
240
| – | – | ﹤0.01% | 769 |
|
|
2018
Q3 | $14K | Buy |
+240
| New | +$14K | ﹤0.01% | 782 |
|